The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 34,030 | 1,551,070 | SH | SOLE | 1,551,070 | 0 | 0 | ||
| AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 3,042 | 336,868 | SH | SOLE | 336,868 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 95,549 | 2,020,911 | SH | SOLE | 2,020,911 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 84,794 | 2,095,231 | SH | SOLE | 2,095,231 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 14,662 | 178,500 | SH | SOLE | 178,500 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 10,617 | 446,641 | SH | SOLE | 446,641 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 29,482 | 1,767,486 | SH | SOLE | 1,767,486 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 5,906 | 982,753 | SH | SOLE | 982,753 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 29,420 | 761,398 | SH | SOLE | 761,398 | 0 | 0 | ||
| CENTURY THERAPEUTICS INC | COM | 15673T100 | 11,144 | 702,623 | SH | SOLE | 702,623 | 0 | 0 | ||
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 8,155 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 761 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
| CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 1,442 | 279,921 | SH | SOLE | 279,921 | 0 | 0 | ||
| CYTEK BIOSCIENCES INC | COM | 23285D109 | 6,528 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 6,940 | 583,649 | SH | SOLE | 583,649 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 17,114 | 1,513,138 | SH | SOLE | 1,513,138 | 0 | 0 | ||
| HELIX ACQUISITION CORP | COM CL A | G4444C102 | 3,956 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| I MAB | SPONSORED ADS | 44975P103 | 49,745 | 1,049,691 | SH | SOLE | 1,049,691 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | 4,881 | 572,862 | SH | SOLE | 572,862 | 0 | 0 | ||
| ITEOS THERAPEUTICS INC | COM | 46565G104 | 20,988 | 450,776 | SH | SOLE | 450,776 | 0 | 0 | ||
| JIYA ACQUISITION CORP | COM CL A | 47760M102 | 2,931 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 19,906 | 340,214 | SH | SOLE | 340,214 | 0 | 0 | ||
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 3,063 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 2,166 | 231,417 | SH | SOLE | 231,417 | 0 | 0 | ||
| OMEGA THERAPEUTICS INC | COMMON STOCK | 68217N105 | 1,999 | 176,470 | SH | SOLE | 176,470 | 0 | 0 | ||
| PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 7,908 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 18,803 | 783,769 | SH | SOLE | 783,769 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 17,928 | 670,940 | SH | SOLE | 670,940 | 0 | 0 | ||